Assuming that adiponectin receptors AdipoR1 and AdipoR2 mediate the antidiabetic and antiinflammatory effects of adiponectin, we hypothesized that genetic variation in AdipoR1 and AdipoR2 may contribute to insulin resistance, dyslipidemia, and inflammation. Here, ADIPOR2 is linked to metabolic syndrome.